Personalised Outcomes in Children With Recurrent Wheeze
Launched by IMPERIAL COLLEGE HEALTHCARE NHS TRUST · Feb 27, 2019
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
The validation of the tool will take place at St Mary's Hospital.
The questionnaire aims to measure
1. incidence of wheeze attacks and use of rescue medications
2. parental/caregiver perception of recurrent wheeze control
3. parental/caregiver perception of effect of recurrent wheeze on family/child quality of life
Participants will be given the questionnaire at the emergency departments or outpatients clinics following having consented to the study and will be asked to fill in the questionnaire and return it to their clinician.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In this study caregivers of preschool children presenting with the second or more episode of wheeze that requires physician review with or without treatment (as per BTS definition of wheeze attack in preschool years) will be included.
- Exclusion Criteria:
- • This study will exclude caregivers who do not consent to complete the questionnaire and therefore participate in the study.
- • This study will exclude caregivers of preschool children who present with their first episode of wheeze.
- • This study will exclude caregivers of preschool children who present with respiratory distress of any other etiology (foreign body inhalation, croup, lower respiratory tract infection, bronchiectasis, exacerbation of cystic fibrosis or ciliopathy)
About Imperial College Healthcare Nhs Trust
Imperial College Healthcare NHS Trust is a leading healthcare provider in London, renowned for its commitment to delivering high-quality patient care and advancing medical research. As an integral part of the NHS, the Trust encompasses a range of specialized services and facilities, including multiple hospitals and outpatient centers, where it fosters a collaborative environment for clinical trials. With a focus on innovation and excellence, Imperial College Healthcare NHS Trust supports a diverse portfolio of clinical research initiatives aimed at translating scientific discoveries into effective treatments and improving health outcomes for patients. Its partnership with Imperial College London enhances its capabilities in cutting-edge research, making it a pivotal institution in the landscape of healthcare and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Mando Watson
Principal Investigator
Imperial College Healthcare NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials